Literature DB >> 12512775

Mechanisms of block of muscle type CLC chloride channels (Review).

Michael Pusch1, Alessio Accardi, Antonella Liantonio, Patrizia Guida, Sonia Traverso, Diana Conte Camerino, Franco Conti.   

Abstract

CLC proteins are a nine-member gene family of Cl- channels that have diverse roles in the plasma membrane and in intracellular organelles. The recent structure determination of bacterial CLC homologues by Dutzler et al. was a breakthrough for the structure-function analysis of CLC channels. This review describes the mechanisms of inhibition of muscle type CLC channels by two classes of small organic substances: 9-anthracene carboxylic acid (9AC) and p-chlorophenoxy propionic acid (CPP). Both substances block muscle type CLC channels (CLC-0 and CLC-1) from the intracellular side. For CPP, one could show that it inhibits the individual protopores of the double-barrelled channel. A major difference between the two types of blockers is the extremely slow binding- and unbinding-kinetics of 9AC (time scale of min), compared to that of CPP block (time scale of s), while the general mechanism of block seems to be quite similar. In the case of the chiral CPP only the S(-) enantiomer is effective. Both substances exhibit a strongly voltage-dependent block with strong inhibition at negative voltages and relief of block at depolarizing potentials at which the channels tend to open maximally. A quantitative kinetic model was developed for the CPP block of CLC-0 in which the closed state has a much larger affinity for CPP than the open state and opening of drug-bound channels is greatly slowed compared to drug-free channels. First experiments with mutated CLC-0 channels and with derivatives of CPP strongly support the pore localization of the CPP binding site. This work provides the basis for the use of these small organic substances as tools to investigate the pharmacological properties of mammalian CLC channels guided by the crystallographic structure of bacterial CLC homologues. They might also turn out to be useful to obtain information about the intricate coupling of gating and permeation that characterizes CLC channels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512775     DOI: 10.1080/09687680210166938

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  14 in total

1.  Mapping ligand binding pockets in chloride ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid.

Authors:  C Altamura; G F Mangiatordi; O Nicolotti; D Sahbani; A Farinato; F Leonetti; M R Carratù; D Conte; J-F Desaphy; P Imbrici
Journal:  Br J Pharmacol       Date:  2018-04-06       Impact factor: 8.739

2.  Exterior site occupancy infers chloride-induced proton gating in a prokaryotic homolog of the ClC chloride channel.

Authors:  David L Bostick; Max L Berkowitz
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

3.  Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.

Authors:  Antonella Liantonio; Annamaria De Luca; Sabata Pierno; Maria Paola Didonna; Fulvio Loiodice; Giuseppe Fracchiolla; Paolo Tortorella; Laghezza Antonio; Elisabetta Bonerba; Sonia Traverso; Laura Elia; Alessandra Picollo; Michael Pusch; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

4.  Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.

Authors:  Alessandra Picollo; Antonella Liantonio; Maria Paola Didonna; Laura Elia; Diana Conte Camerino; Michael Pusch
Journal:  EMBO Rep       Date:  2004-05-28       Impact factor: 8.807

5.  Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.

Authors:  A Liantonio; V Giannuzzi; A Picollo; E Babini; M Pusch; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-11-27       Impact factor: 8.739

6.  Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel.

Authors:  Anna K Koster; Austin L Reese; Yuri Kuryshev; Xianlan Wen; Keri A McKiernan; Erin E Gray; Caiyun Wu; John R Huguenard; Merritt Maduke; J Du Bois
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-04       Impact factor: 12.779

7.  The Concise Guide to PHARMACOLOGY 2013/14: ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; William A Catterall; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

8.  ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.

Authors:  P Imbrici; L Maggi; G F Mangiatordi; M M Dinardo; C Altamura; R Brugnoni; D Alberga; G Lauria Pinter; G Ricci; G Siciliano; R Micheli; G Annicchiarico; G Lattanzi; O Nicolotti; L Morandi; P Bernasconi; J-F Desaphy; R Mantegazza; D Conte Camerino
Journal:  J Physiol       Date:  2015-07-14       Impact factor: 5.182

9.  Gating competence of constitutively open CLC-0 mutants revealed by the interaction with a small organic Inhibitor.

Authors:  Sonia Traverso; Laura Elia; Michael Pusch
Journal:  J Gen Physiol       Date:  2003-08-11       Impact factor: 4.086

10.  A chloride channel blocker prevents the suppression by inorganic phosphate of the cytosolic calcium signals that control muscle contraction.

Authors:  Juan J Ferreira; Germán Pequera; Bradley S Launikonis; Eduardo Ríos; Gustavo Brum
Journal:  J Physiol       Date:  2020-10-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.